Minocycline nanoplatform penetrates the BBB and enables the targeted treatment of Parkinson's disease with cognitive impairment

Autor: Cheng, Guowang, Liu, Zhiwen, Yan, Zhao, Wu, Jiaxin, Li, Zilin, Gao, Sijia, Zheng, Chunye, Guo, Shuanshuan, Pan, Yue, Chen, Xiaojia, Lin, Guanghui, Zhou, Jianhua, Chen, Tongkai

Publikováno v: In Journal of Controlled Release 10 January 2025 377:591-605

The valuable role of dynamic 18F FDG PET/CT-derived kinetic parameter [formula omitted] in patients with nasopharyngeal carcinoma prior to radiotherapy: A prospective study

Autor: Huang, Xiaotao, Zhuang, Mingzan, Yang, Shuai, Wang, Ying, Liu, Qiaodan, Xu, Xiwei, Xiao, Mei, Peng, Yingpeng, Jiang, Ping, Xu, Wenhua, Guo, Shuanshuan, Wang, Rong, Wei, Wei, Zhong, Guihua, Zhou, Yuling, Peng, Shunli, Li, Xuanzi, Cui, Jianqi, Wang, Siyang, Zhang, Yaqin, Liu, Zhigang

Publikováno v: In Radiotherapy and Oncology February 2023 179

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Minocycline nanoplatform penetrates the BBB and enables the targeted treatment of Parkinson's disease with cognitive impairment.

Autor: Cheng G; School of Pharmaceutical Sciences, Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China., Liu Z; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China; School of Life Sciences and Biopharmaceutics, Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, Guangdong Pharmaceutical University, Guangzhou, 510006, China., Yan Z; School of Pharmaceutical Sciences, Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China., Wu J; School of Pharmaceutical Sciences, Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China., Li Z; School of Pharmaceutical Sciences, Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China., Gao S; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau 999078, China., Zheng C; Department of Neurology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China., Guo S; School of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong 518107, China., Pan Y; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China., Chen X; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau 999078, China. Electronic address: xiaojiachen@um.edu.mo., Lin G; School of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong 518107, China. Electronic address: lingh29@mail2.sysu.edu.cn., Zhou J; School of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong 518107, China., Chen T; School of Pharmaceutical Sciences, Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China. Electronic address: chentongkai@gzucm.edu.cn.

Publikováno v: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2024 Nov 29; Vol. 377, pp. 591-605. Date of Electronic Publication: 2024 Nov 29.